
Dolutegravir Improves Long-Term HIV Outcomes in Children and Adolescents
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNR09GZGNQM3hfNFVsd1FxelA1VFpWTzkxdFliZFdMLXVFWHdFZnh5bXNkcGdqYWJycEQ4TWhRRDZOVHFGbkswX0hpcE1ucFlwTGhLUGpOTmlJQVhqaU1sb2V6TDRaZW9NN0taYnNFeFJ4cE93cVpzb1ByQlVHUURRR1V1TEw4bWdGdnBqeS1YdVVkQ3d3N3N5aERvbG1hRGptckNoM3MwQ3I0N0pfOTZUMWhOSURlcmVQZnF3?oc=5" target="_blank">Dolutegravir Improves Long-Term HIV Outcomes in Children and Adolescents</a>&nbsp;&nbsp;<font color="#6f6f6f">Infectious Disease Advisor</font>

